14034 Federal Register / Vol. 76, No. 50 / Tuesday, March 15, 2011 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; Comment 

Request; A Generic Submission for 

Formative Research, Pretesting, 

Stakeholder Measures and Advocate 

Forms at NCI 

SUMMARY: Under the provisions of 

Section 3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, for opportunity 

for public comment on proposed data 

collection projects, the National Cancer 

Institute (NCI), the National Institutes of 

Health (NIH) will publish periodic 

summaries of proposed projects to be 

submitted to the Office of Management 

and Budget (OMB) for review and 

approval. 

Proposed Collection: Title: A Generic 

Submission for Formative Research, Pretesting, Stakeholder Measures and 

Advocate Forms at NCI. Type of 

Information Collection Request: New. 

Need and Use of Information Collection: 

In order to carry out NCI’s legislative 

mandate, the Office of Advocacy 

Relations (OAR) disseminates cancerrelated information to a variety of 

stakeholders, seeks their input and 

feedback, and facilitates collaboration 

between the Institute and these external 

partners to advance NCI’s authorized 

programs. It is beneficial for NCI, 

through the OAR, to pretest strategies, 

concepts, activities and materials while 

they are under development. 

Additionally, administrative forms may 

be part of this generic submission since 

they are a necessary part of collecting 

demographic information and areas of 

interest for advocates. Pre-testing, or 

formative evaluation, helps ensure that 

the products and services developed by 

NCI have the greatest capacity of being 

received, understood, and accepted by 

their target audiences. Since OAR is 

responsible for matching advocates to 

NCI programs and initiatives across the 

cancer continuum, it is necessary to 

measure the satisfaction of both internal 

and external stakeholders with this 

collaboration. This customer satisfaction 

research helps ensure the relevance, 

utility, and appropriateness of the many 

initiatives and products that OAR and 

NCI produce. The OAR will use a 

variety of qualitative (focus groups, 

interviews) and quantitative (paper, 

phone, in-person, and web surveys) 

methodologies to conduct this research, 

allowing NCI to: (1) Understand 

characteristics (attitudes, beliefs, and 

behaviors) of the intended target 

audience and use this information in the 

development of effective strategies, 

concepts, activities; (2) use a feedback 

loop to help refine, revise, and enhance 

OAR’s efforts—ensuring that they have 

the greatest relevance, utility, 

appropriateness, and impact for/to 

target audiences; and (3) expend limited 

program resource dollars wisely and 

effectively. Frequency of Response: On 

occasion. Affected Public: Individuals or 

households; Businesses or other for 

profit; Not-for-profit institutions and 

organizations; Federal Government; 

State, Local, or Tribal Government. Type 

of Respondents: Adult cancer research 

advocates; members of the public; 

health care professionals; organizational 

representatives. Table 1 outlines the 

estimated burden hours required for a 

three-year approval of this generic 

submission. There are no Capital Costs, 

Operating Costs, and/or Maintenance 

Costs to report. 

TABLE 1—ESTIMATE OF BURDEN HOURS OVER THREE YEARS

[For generic submissions] 

Survey/Instrument Number of 

respondents 

Frequency of 

response 

Average time 

per response 

(minutes/hour) 

Annual burden 

hours 

Self-Administered Post-Activity Questionnaires .............................................. 3,600 1 20/60 (.33) 1,200 

Other Self-Administered Questionnaires and Forms ....................................... 1,800 1 60/60 (1.0) 1,800 

Individual In-Depth Interviews ......................................................................... 225 1 60/60 (1.0) 225 

Focus Group Interviews ................................................................................... 300 1 90/60 (1.5) 450 

Totals ........................................................................................................ 5,925 ........................ ........................ 3,675 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

on one or more of the following points: 

(1) Whether the proposed collection of 

information is necessary for the proper 

performance of the function of the 

agency, including whether the 

information will have practical utility; 

(2) The accuracy of the agency’s 

estimate of the burden of the proposed 

collection of information, including the 

validity of the methodology and 

assumptions used; (3) Ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

Ways to minimize the burden of the 

collection of information on those who 

are to respond, including the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans, contact 

Shannon Bell, Director of Office of 

Advocacy Relations (OAR), NCI, NIH, 

31 Center Drive, Bldg. 31, Room 10A28, 

MSC 2580, Bethesda, MD 20892, call 

non-toll-free number 301–451–3393 or 

e-mail your request, including your 

address to: bells@mail.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 60 days of the date of 

this publication. 

Dated: March 9, 2011. 

Vivian Horovitch-Kelley, 

NCI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 2011–6022 Filed 3–14–11; 8:45 am] 

BILLING CODE 4101–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; Comment 

Request; NCI Cancer Genetics 

Services Directory Web-Based 

Application Form and Update Mailer 

Summary: In compliance with the 

requirement of Section 3506(c)(2)(A) of 

the Paperwork Reduction Act of 1995, 

for opportunity for public comment on 

proposed data collection projects, the 

National Cancer Institute (NCI), the 

National Institutes of Health (NIH) will 

publish periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

Proposed Collection: Title: NCI Cancer 

Genetics Services Directory Web-based 

Application Form and Update Mailer. 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 76, No. 50 / Tuesday, March 15, 2011 / Notices 14035 

Type of Information Collection Request: 

Existing Collection in Use Without an 

OMB Number. Need and Use of 

Information Collection: The purpose of 

the online application form and the 

Web-based update mailer is to collect 

information about genetics professionals 

to be included in the NCI Cancer 

Genetics Services Directory on NCI’s 

Cancer.gov Web site. The information 

collected includes name, practice 

locations, professional qualifications, 

and areas of specialization. Frequency of 

Response: Information is collected once 

via the online application form, and 

then updated annually via the Webbased mailer. Affected Public: 

Individuals. Type of Respondents: 

Genetics professionals including nurses, 

physicians, genetic counselors, and 

other professionals who provide 

services related to cancer genetics. The 

annual reporting burden is estimated at 

180 hours (see Table below). There are 

no Capital Costs, Operating Costs, and/ 

or Maintenance Costs to report. 

TABLE 1—ESTIMATES OF ANNUAL BURDEN HOURS

Type of respondents Tool Number of 

respondents 

Frequency of 

response 

Average time 

per response 

minutes/hour 

(hours) 

Annual burden 

hours 

Genetics Professionals ........................... Application Form ......................... 60 1 30/60 

(.50) 

30 

Web-based Update Mailer .......... 600 1 15/60 

(0.25) 

150 

Totals ............................................... ..................................................... 660 ........................ ........................ 180 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies should 

address one or more of the following 

points: (1) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the function of the agency, including 

whether the information will have 

practical utility; (2) Evaluate the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Minimize the burden 

of the collection of information on those 

who are to respond, including the use 

of appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

For Further Information Contact: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact Margaret Beckwith, 

Acting Branch Chief, International 

Cancer Research Databank Branch, 

Office of Cancer Content Management, 

Office of Communication and 

Education, National Cancer Institute, 

6116 Executive Blvd., Rockville, MD 

20852, or call non-toll-free number 301– 

496–9096 or e-mail your request, 

including your address to: 

mbeckwit@mail.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 60 days of the date of 

this publication. 

Dated: March 9, 2011. 

Vivian Horovitch-Kelley, 

NCI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 2011–6021 Filed 3–14–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Establishment 

Pursuant to the Federal Advisory 

Committee Act, as amended (5 U.S.C. 

app.), the Director, National Institutes of 

Health (NIH), announces the 

establishment of the NCI-Frederick 

Advisory Committee. 

The Council will provide advice and 

recommendations to the Director, 

National Cancer Institute (NCI), and the 

Associate Director, NCI-Frederick, on 

the optimal use of the NCI-Frederick 

facility to rapidly meet the most urgent 

needs of the NCI. The Committee will 

consist of 16 members, including the 

Chair, appointed by the Director, NCI. 

Members will be authorities 

knowledgeable in drug and vaccine 

development, clinical trials support, 

AIDS research, bioinformatics, 

genomics, nanotechnology, biological 

repositories, and basic research in 

immunology and infectious diseases. 

Duration of this committee is 

continuing unless formally determined 

by the Director, NCI that termination 

would be in the best interest of the 

public. 

Dated: March 9, 2011. 

Francis S. Collins, 

Director, National Institutes of Health. 

[FR Doc. 2011–6023 Filed 3–14–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel; Career 

Development, Research Training and 

Pathways to Independence Grant Review. 

Date: March 29, 2011. 

Time: 10 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 


srobinson on DSKHWCL6B1PROD with NOTICES